[
  {
    "ts": "2026-02-10T10:01:00+00:00",
    "headline": "Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data",
    "summary": "Precedence Research, a leading strategic research firm, presents an in-depth analysis of the Tissue and Regenerative Engineering market, highlighting key company performance, product focus, and government funding initiatives. Tissue engineering and regenerative biomaterials are advancing rapidly, with innovations in scaffolds, bio-inks, and engineered tissues enabling applications in wound healing, reconstructive surgery, and orthopedic repair.Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According",
    "url": "https://finance.yahoo.com/news/tissue-regenerative-engineering-market-company-100100919.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "3c809dce-51fb-3e15-af61-a2eff346796a",
      "content": {
        "id": "3c809dce-51fb-3e15-af61-a2eff346796a",
        "contentType": "STORY",
        "title": "Tissue and Regenerative Engineering Market Company, Government & Public Sector Funding Data",
        "description": "",
        "summary": "Precedence Research, a leading strategic research firm, presents an in-depth analysis of the Tissue and Regenerative Engineering market, highlighting key company performance, product focus, and government funding initiatives. Tissue engineering and regenerative biomaterials are advancing rapidly, with innovations in scaffolds, bio-inks, and engineered tissues enabling applications in wound healing, reconstructive surgery, and orthopedic repair.Ottawa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- According",
        "pubDate": "2026-02-10T10:01:00Z",
        "displayTime": "2026-02-10T10:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7",
          "originalWidth": 1667,
          "originalHeight": 1667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2XVm_GDF06LCL8xJEgs9kg--~B/aD0xNjY3O3c9MTY2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 1667,
              "height": 1667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ciHBcKYhN1HkkZYm0oIo1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tissue-regenerative-engineering-market-company-100100919.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tissue-regenerative-engineering-market-company-100100919.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VCEL"
            },
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T11:36:36+00:00",
    "headline": "Zimmer: Q4 Earnings Snapshot",
    "summary": "The Warsaw, Indiana-based company said it had net income of 70 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $2.42 per share. The results beat Wall Street expectations.",
    "url": "https://finance.yahoo.com/news/zimmer-q4-earnings-snapshot-113636888.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "6d55fa1e-04be-3453-8af0-e1a96fcdceb7",
      "content": {
        "id": "6d55fa1e-04be-3453-8af0-e1a96fcdceb7",
        "contentType": "STORY",
        "title": "Zimmer: Q4 Earnings Snapshot",
        "description": "",
        "summary": "The Warsaw, Indiana-based company said it had net income of 70 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $2.42 per share. The results beat Wall Street expectations.",
        "pubDate": "2026-02-10T11:36:36Z",
        "displayTime": "2026-02-10T11:36:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-q4-earnings-snapshot-113636888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-q4-earnings-snapshot-113636888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T11:30:00+00:00",
    "headline": "Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025. The Company reported fourth quarter net sales of $2.244 billion, an increase of 10.9% over the prior year period, an increase of 9.2% on a constant currency1 basis and an increase of 5.4% on an organic constant currency1 basis. Net sales for the full year were $8.232 billion, an increase of 7.2% over the prior year, an increase of 6.4% on a constant currency1 basis",
    "url": "https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000014.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "6f96cf05-3f1e-30e1-b3a5-a05512ecd4be",
      "content": {
        "id": "6f96cf05-3f1e-30e1-b3a5-a05512ecd4be",
        "contentType": "STORY",
        "title": "Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results",
        "description": "",
        "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025. The Company reported fourth quarter net sales of $2.244 billion, an increase of 10.9% over the prior year period, an increase of 9.2% on a constant currency1 basis and an increase of 5.4% on an organic constant currency1 basis. Net sales for the full year were $8.232 billion, an increase of 7.2% over the prior year, an increase of 6.4% on a constant currency1 basis",
        "pubDate": "2026-02-10T11:30:00Z",
        "displayTime": "2026-02-10T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286",
          "originalWidth": 400,
          "originalHeight": 101,
          "caption": "(PRNewsfoto/Zimmer Biomet Holdings, Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GP_teg8ss0fGgaZjpeJs_A--~B/aD0xMDE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286.cf.webp",
              "width": 400,
              "height": 101,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ifZOCqpAIJQAT2DcWs2m_Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000014.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000014.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]